Orient Europharma Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 09, 2020 at 05:43 pm
Share
Orient EuroPharma Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 1,167.706 million compared to TWD 1,469.796 million a year ago. Net loss was TWD 13.378 million compared to net income of TWD 31.168 million a year ago. Basic loss per share was TWD 0.15 compared to basic earnings per share of TWD 0.36 a year ago. For the nine months, sales was TWD 4,062.166 million compared to TWD 4,491.449 million a year ago. Net income was TWD 232.933 million compared to TWD 214.472 million a year ago. Basic earnings per share was TWD 2.69 compared to TWD 2.47 a year ago. Diluted earnings per share was TWD 2.68 compared to TWD 2.46 a year ago.
Orient Europharma Co., Ltd. is principally engaged in the manufacture and distribution of nutritious healthcare products and medical cosmetic products, as well as western drugs. The Company operates nutritious healthcare products and medical cosmetic products segment, providing infant milk powders, nutritious products and functional healthcare products, as well as dermatological preparations, medical hair care series, organic skin care series and medical make-up products, among others; western drugs segment, providing products for cardiovascular diseases, cancer, blood diseases, diabetes, central nervous system diseases and asthma, among others.
ORIENT EUROPHARMA CO., LTD. 
